Related Experiment Videos
Transient erythroblastopenia of childhood in infants < 6 months of age
1Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, School of Medicine, Cleveland, Ohio 44106.
Insights
Transient erythroblastopenia of childhood (TEC) is more common in infants under 6 months than previously thought. Early recognition of TEC in infants is crucial to avoid misdiagnosis of Diamond Blackfan anemia (DBA).
Area of Science:
- Pediatric Hematology
- Neonatal Medicine
- Clinical Diagnostics
Background:
- Severe aregenerative anemia in infants under 6 months can mimic Diamond Blackfan anemia (DBA).
- Distinguishing between TEC and DBA is critical due to differing prognoses and treatments.
Purpose of the Study:
- To report the occurrence of Transient Erythroblastopenia of Childhood (TEC) in infants younger than 6 months.
- To highlight the clinical and hematologic similarities between TEC in young infants and older children.
Main Methods:
- Retrospective identification of six infants under 6 months diagnosed with TEC over a 6-year period.
- Analysis of clinical presentation, including anemia, reticulocytopenia, and hematologic parameters.
Main Results:
- All identified infants presented with moderate to severe anemia and reticulocytopenia.
- The hematologic profile of TEC in these young infants was similar to that observed in older children.
Conclusions:
- TEC may be underrecognized in infants younger than 6 months.
- Recognizing TEC in this age group can prevent misdiagnosis of Diamond Blackfan anemia (DBA).
Purpose:
During a 6-year period, we identified six infants < 6 months of age with transient erythroblastopenia of childhood (TEC).
Patients And Methods:
All patients presented with moderate to severe anemia, reticulocytopenia, and age-appropriate mean corpuscular volume and fetal hemoglobin level.
Results:
Severe aregenerative anemia in an infant < 6 months of age often raises the diagnostic possibility of Diamond Blackfan anemia (DBA). Given prognostic and therapeutic implications, distinction between DBA and TEC is of crucial importance.
Conclusions:
We suggest that TEC may occur more commonly in infants < 6 months of age than has heretofore been recognized and that it has a clinical and hematologic picture similar to that seen in older children. Recognition of the occurrence of TEC in very young infants may help avoid an inappropriate diagnosis of DBA.